Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GILD · against 20 other Healthcare companies of similar size
Ranked #21 of 21 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score1 peers with a profitability score of 30–39, including GILD · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | GILD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 21 reported | -5.7% | 11.5% | 0% | 33% | |
| Operating marginHigher is better · 21 reported | -8.2% | 21.4% | 0% | 33% | |
| Return on assetsHigher is better · 21 reported | -6.6% | 6.2% | 0% | 33% | |
| Return on equityHigher is better · 20 reported | -20.7% | 15.3% | 0% | Context only | |
| Gross marginHigher is better · 21 reported | 79.6% | 71.7% | 90% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 99 | 71 | |
| 2 | 317.9B CHF (≈$365.6B) | 97 | 60 | |
| 3 | 134.5B USD | 96 | 70 | |
| 4 | 155.7B USD | 94 | 64 | |
| 4 | 302.7B USD | 94 | 63 | |
| 17 | 363.0B USD | 61 | 47 | |
| 18 | 126.5B USD | 60 | 56 | |
| 19 | 356.9B USD | 55 | 37 | |
| 20 | 116.9B USD | 44 | 47 | |
| 21 | 207.7B USD | 30 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score